Company / PP&E (Net)
Warby Parker Inc. PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$187.4M
FY2025
5-year range
$112.2M / $187.4M
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#69 of 132
Health Care
What the data says
At $187M, Warby Parker Inc.'s pp&e (net) ranks #69 of 132 in the Health Care sector. PP&E (Net) has increased for 5 consecutive years, from $85M in FY2020 to $187M in FY2025.
Based on SEC 10-K filings.
$187M in FY2025 with a 5-year CAGR of +17.3%.
Improved from $152M to $187M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +10.6%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
#69 of 132 in Health CareTop 52% of 132This company $187.4M Sector average $1.4B
▼
-86.9% below sector average
Key checks
Key Insights
- Warby Parker Inc.'s pp&e (net) has grown for 5 consecutive years.
- 5-year CAGR of +17.3%, indicating consistent growth.
- In FY2025, pp&e (net) increased 10.0% year-over-year.
- Ranks #69 out of 132 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $187.4M | +10.0% |
| FY2024 | $170.5M | +11.9% |
| FY2023 | $152.3M | +9.9% |
| FY2022 | $138.6M | +23.6% |
| FY2021 | $112.2M | +32.7% |
| FY2020 | $84.5M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026